NCT05688852: An ongoing trial by Ventyx Biosciences, Inc
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05688852 |
|---|---|
| Title | A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of VTX958 in Participants With Moderately to Severely Active Crohn's Disease |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 25, 2023 |
| Completion date | June 27, 2024 |
| Required reporting date | June 27, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |